معرفی
William S. Messer is a Professor at the University of Toledo, affiliated with the College of Pharmacy and Pharmaceutical Sciences and the Department of Pharmacology and Experimental Therapeutics. His career spans over three decades, focusing on the development of novel treatments for neurological and psychiatric disorders, particularly Alzheimer's disease, schizophrenia, and autism spectrum disorders, through the study of muscarinic acetylcholine receptors and small molecule synthesis.
- Education:
- Ph.D. and M.S. in Neuroscience, University of Rochester
- B.S. in Biology, Springfield College
Dr. Messer’s research integrates in vitro and in vivo methodologies to explore receptor activation, memory processes, and cognitive function. His work has led to the development of compounds like CDD-0102A, a selective M1 muscarinic agonist, and the founding of pharmaceutical companies Cognitive Pharmaceuticals Ltd. and Psyneurgy Pharmaceuticals LLC. Recent publications highlight his investigations into allosteric modulators of muscarinic receptors, memory destabilization mechanisms, and zebrafish/mouse models of neurological conditions.
His team’s efforts have advanced compounds into preclinical and Phase I clinical trials, emphasizing translational impact. Dr. Messer also contributes to theoretical chemistry and analytical techniques in neuropharmacology.
